167 related articles for article (PubMed ID: 38092421)
1. Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.
Cui Q; Huang C; Liu JY; Zhang JT
J Med Chem; 2023 Dec; 66(24):16515-16545. PubMed ID: 38092421
[TBL] [Abstract][Full Text] [Related]
2. Targeting survivin for therapeutic discovery: past, present, and future promises.
Peery RC; Liu JY; Zhang JT
Drug Discov Today; 2017 Oct; 22(10):1466-1477. PubMed ID: 28577912
[TBL] [Abstract][Full Text] [Related]
3. A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells.
Peery R; Cui Q; Kyei-Baffour K; Josephraj S; Huang C; Dong Z; Dai M; Zhang JT; Liu JY
Bioorg Med Chem; 2022 Jul; 65():116761. PubMed ID: 35504208
[TBL] [Abstract][Full Text] [Related]
4. Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors.
Qi J; Dong Z; Liu J; Peery RC; Zhang S; Liu JY; Zhang JT
Cancer Res; 2016 Jan; 76(2):453-62. PubMed ID: 26744521
[TBL] [Abstract][Full Text] [Related]
5. Survivin (BIRC5): Implications in cancer therapy.
Siragusa G; Tomasello L; Giordano C; Pizzolanti G
Life Sci; 2024 Aug; 350():122788. PubMed ID: 38848940
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation.
Peery R; Kyei-Baffour K; Dong Z; Liu J; de Andrade Horn P; Dai M; Liu JY; Zhang JT
J Med Chem; 2020 Jul; 63(13):7243-7251. PubMed ID: 32421328
[TBL] [Abstract][Full Text] [Related]
7. Survivin Small Molecules Inhibitors: Recent Advances and Challenges.
Albadari N; Li W
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771042
[TBL] [Abstract][Full Text] [Related]
8. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development.
Kondapuram SK; Ramachandran HK; Arya H; Coumar MS
Life Sci; 2023 Dec; 335():122260. PubMed ID: 37963509
[TBL] [Abstract][Full Text] [Related]
9. Chemically synthesized human survivin does not inhibit caspase-3.
Li C; Wu Z; Liu M; Pazgier M; Lu W
Protein Sci; 2008 Sep; 17(9):1624-9. PubMed ID: 18539906
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy.
Wang S; Xu Y; Chan HF; Kim HW; Wang Y; Leong KW; Chen M
J Control Release; 2016 Oct; 240():454-464. PubMed ID: 27091696
[TBL] [Abstract][Full Text] [Related]
11. Discovery of survivin inhibitors and beyond: FL118 as a proof of concept.
Li F
Int Rev Cell Mol Biol; 2013; 305():217-52. PubMed ID: 23890383
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological studies of survivin dimerization modulators that prolong mitotic cycle.
Chettiar SN; Cooley JV; Park IH; Bhasin D; Chakravarti A; Li PK; Li C; Jacob NK
Bioorg Med Chem Lett; 2013 Oct; 23(19):5429-33. PubMed ID: 23968825
[TBL] [Abstract][Full Text] [Related]
13. Targeting survivin in cancer: novel drug development approaches.
Groner B; Weiss A
BioDrugs; 2014 Feb; 28(1):27-39. PubMed ID: 23955284
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Novel 3-Cyanopyridines as Survivin Modulators and Apoptosis Inducers.
Sabour R; Harras MF; Mohamed Al Kamaly O; Altwaijry N
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105831
[TBL] [Abstract][Full Text] [Related]
15. Pioneering 4,11-Dioxo-4,11-dihydro-1
Yuan J; Liu Z; Dong Y; Gao F; Xia X; Wang P; Luo Y; Zhang Z; Yan D; Zhang W
J Med Chem; 2023 Dec; 66(24):16843-16868. PubMed ID: 38079530
[TBL] [Abstract][Full Text] [Related]
16. Survivin as a prognostic/predictive marker and molecular target in cancer therapy.
Rödel F; Sprenger T; Kaina B; Liersch T; Rödel C; Fulda S; Hehlgans S
Curr Med Chem; 2012; 19(22):3679-88. PubMed ID: 22680927
[TBL] [Abstract][Full Text] [Related]
17. Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.
Groner B; Weber A; Mack L
Bioengineered; 2012; 3(6):320-5. PubMed ID: 22825353
[TBL] [Abstract][Full Text] [Related]
18. Investigations of survivin: the past, present and future.
Cheung CH; Cheng L; Chang KY; Chen HH; Chang JY
Front Biosci (Landmark Ed); 2011 Jan; 16(3):952-61. PubMed ID: 21196211
[TBL] [Abstract][Full Text] [Related]
19. Survivin in survival of hepatocellular carcinoma.
Su C
Cancer Lett; 2016 Sep; 379(2):184-90. PubMed ID: 26118774
[TBL] [Abstract][Full Text] [Related]
20. The role of survivin for radiation oncology: moving beyond apoptosis inhibition.
Rödel F; Reichert S; Sprenger T; Gaipl US; Mirsch J; Liersch T; Fulda S; Rödel C
Curr Med Chem; 2011; 18(2):191-9. PubMed ID: 21110807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
